RPS6KB1 and myeloid sarcoma: The top four pathways (eIF2 signaling, regulation of eIF4 and p70S6K signaling, Coronavirus pathogenesis pathway, and mTOR signaling) identified among the proteins exclusively changed in MS patients corresponded to the top four pathways identified among the proteins whose expression were changed upon T cell activation in both groups (Table 6).